1. Use of antibodies against Epstein-Barr virus nuclear antigen 1 for detection of cellular proteins with monomethylated arginine residues that are potentially involved in viral transformation.
- Author
-
Graesser C, Nord R, Flaswinkel H, Kremmer E, Meese E, Caban KM, Fröhlich T, Grässer FA, and Hart M
- Subjects
- Humans, Animals, Mice, Cell Transformation, Viral, Antibodies, Monoclonal immunology, Epstein-Barr Virus Nuclear Antigens immunology, Epstein-Barr Virus Nuclear Antigens chemistry, Epstein-Barr Virus Nuclear Antigens genetics, Herpesvirus 4, Human immunology, Herpesvirus 4, Human genetics, Arginine metabolism, Arginine chemistry
- Abstract
Epstein-Barr virus nuclear antigen 1 (EBNA1) contains two arginine-glycine (RG) repeats that contain symmetric/asymmetric dimethylarginine (SDMA/ADMA) and monomethylarginine (MMA) residues. We generated mouse monoclonal antibodies directed against a monomethylated GRGRGG-containing repeat located between amino acids 328 and 377 of EBNA1. In addition to detecting MMA-modified EBNA1, we also had the goal of identifying cellular proteins that bind to MMA-modified EBNA1 in EBV-positive Raji cells. Furthermore, we hypothesized that antibodies against MMA-modified EBNA1 might also recognize cell factors that use an MMA-modified surface structure similar to that of EBNA1 to bind to their common targets. Using a combination of immunoprecipitation and mass spectrometry, we identified a number of such cellular proteins, including SNRPD1-3, ALY/REF, RPS15, DIDO1, LSM12, LSM14A, DAP3, and CPSF1. An NACA complex protein that was shown previously to bind to the glycine-alanine repeat of EBNA1 was also identified. The proteins identified in this study are involved in splicing, tumorigenesis, transcriptional activation, DNA stability, and RNA processing or export., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF